DRMA — DERMATA THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | 54.1% | -3805.7% | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 15 SEC-registered investment managers reported holding DRMA (DERMATA THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $186.81K across 170.14K shares. That is -6.9% by share count (-5.24K shares) versus the previous quarter, while reported value moved -20.6%. Ownership is concentrated: the five largest holders account for 65.2% of reported value and the top ten for 99.7%.
Compared with the prior quarter, 7 opened new positions, 2 added to existing stakes, 3 trimmed, 5 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of DERMATA THERAPEUTICS INC (DRMA) include ARMISTICE CAPITAL, LLC, Clear Street Group Inc., Citadel Advisors, ranked by reported 13F value among the 31 institutional holders on this page.
DRMA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 15 | 170.14K | $186.81K | -6.9% |
| Q2 2026 | 13 | 123.97K | $159.92K | -41.1% |
| Q1 2026 | 7 | 106.49K | $128.85K | +991.5% |
| Q4 2025 | 7 | 26.89K | $62.39K | -35.8% |
| Q3 2025 | 5 | 92.23K | $463.00K | -78.0% |
| Q2 2025 | 10 | 508.15K | $297.50K | -11.2% |
| Q1 2025 | 8 | 518.51K | $561.19K | +967.7% |
| Q4 2024 | 6 | 45.53K | $61.47K | +168.9% |
Over the 8 quarters shown, institutional share counts increased 274% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2026 (+991.5%).
Top Institutional Holders (Q3 2026) — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 32.80K | $36.08K | 0.00% | New | |
| 20.10K | $22.11K | 0.00% | Reduce | |
| 20.00K | $22.00K | 0.00% | Hold | |
| 19.40K | $21.00K | 0.00% | New | |
| 18.75K | $20.62K | 0.00% | New | |
| 17.11K | $18.83K | 0.00% | Add | |
| 16.59K | $18.25K | 0.00% | New | |
| 12.88K | $14.16K | 0.00% | Reduce | |
| 6.62K | $7.29K | 0.00% | New | |
| 5.44K | $5.98K | 0.00% | New | |
| 313 | $344 | 0.00% | Reduce | |
| 102 | $112 | 0.00% | Add | |
| 26 | $29 | 0.00% | Hold | |
| 3 | $3 | 0.00% | New | |
| 2 | $2 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 20.20K | $26.06K | 0.00% | New | |
| 20.20K | $26.06K | 0.00% | Reduce | |
| 20.00K | $25.80K | 0.00% | Hold | |
| 16.80K | $21.67K | 0.00% | Reduce | |
| 15.99K | $20.63K | 0.00% | New | |
| 14.79K | $19.07K | 0.00% | New | |
| 10.00K | $12.90K | 0.00% | New | |
| 3.86K | $4.98K | 0.00% | Add | |
| 1.73K | $2.23K | 0.00% | Hold | |
| 270 | $348 | 0.00% | New | |
| 101 | $130 | 0.00% | Hold | |
| 26 | $34 | 0.00% | New | |
| 2 | $3 | 0.00% | New |
Q1 2026 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 48.33K | $58.48K | 0.00% | New | |
| 35.61K | $43.09K | 0.00% | Add | |
| 20.00K | $24.20K | 0.00% | New | |
| 1.73K | $2.10K | 0.00% | New | |
| 716 | $866 | 0.00% | Reduce | |
| 101 | $122 | 0.00% | Hold | |
| 1 | $1 | 0.00% | New |
Q4 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 17.00K | $39.44K | 0.00% | New | |
| 3.46K | $8.02K | 0.00% | Add | |
| 2.40K | $5.57K | 0.00% | New | |
| 2.00K | $4.64K | 0.00% | Add | |
| 1.24K | $2.87K | 0.00% | Reduce | |
| 696 | $1.61K | 0.00% | New | |
| 101 | $234 | 0.00% | Hold |
Q3 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 81.65K | $409.90K | 0.01% | Reduce | |
| 10.05K | $50.44K | 0.00% | Reduce | |
| 426 | $2.14K | 0.00% | Reduce | |
| 101 | $507 | 0.00% | Reduce | |
| 4 | $20 | 0.00% | Reduce |
Q2 2025 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 322.18K | $188.47K | 0.00% | Reduce | |
| 90.95K | $53.21K | 0.00% | Add | |
| 34.49K | $20.18K | 0.00% | New | |
| 27.39K | $16.02K | 0.00% | Add | |
| 14.72K | $8.61K | 0.00% | New | |
| 12.00K | $7.25K | 0.00% | Hold | |
| 5.32K | $3.11K | 0.00% | Add | |
| 1.01K | $591 | 0.00% | Add | |
| 60 | $35 | 0.00% | New | |
| 31 | $18 | 0.00% | Add |
New Positions (Q3 2026)
- Citadel Advisors 32.80K sh · $36.08K
- HRT FINANCIAL LP 19.40K sh · $21.00K
- STATE STREET CORP 18.75K sh · $20.62K
- JANE STREET GROUP, LLC 16.59K sh · $18.25K
- Citigroup Inc 6.62K sh · $7.29K
- VANGUARD CAPITAL MANAGEMENT LLC 5.44K sh · $5.98K
- JPMorgan Chase & Co 3 sh · $3
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 20.20K sh · $26.06K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP sold 15.99K sh · $20.63K
- Advisory Alpha, LLC sold 10.00K sh · $12.90K
- MCF Advisors LLC sold 1.73K sh · $2.23K
- BARCLAYS PLC sold 270 sh · $348
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | 32.80K | — | — | — | — | — | — | — | — | — | 17.49K | — | — | 17.19K | — | — | — | 79.97K | — | — |
| Geode Capital Management | 20.10K | 20.20K | 48.33K | — | — | 27.39K | 20.41K | — | — | — | 12.24K | 12.24K | 12.24K | — | — | 26.67K | 26.67K | 26.67K | 26.67K | 26.67K |
| WELCH & FORBES LLC | 20.00K | 20.00K | 20.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 19.40K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 18.75K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 17.11K | 16.80K | 35.61K | 1.24K | 10.05K | 90.95K | 70.29K | 13.87K | 1.50K | 1.71K | — | — | 131 | 7.01K | 3.44K | 37.31K | 14.80K | 11.21K | 4.32K | — |
| JANE STREET GROUP, LLC | 16.59K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| XTX Topco Ltd | 12.88K | 14.79K | — | — | — | 34.49K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | 6.62K | — | 1 | — | — | 60 | — | — | — | — | — | — | — | — | — | — | — | 48.94K | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.44K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 313 | 3.86K | 716 | 2.00K | 426 | 5.32K | 1.80K | 1.39K | 2.89K | 1.73K | 5.74K | 6.42K | 5.14K | — | — | — | — | — | — | — |
| SBI Securities Co., Ltd. | 102 | 101 | 101 | 101 | 101 | 1.01K | 1.00K | 1.00K | — | — | — | — | — | — | — | — | — | — | — | — |
| HIGHLINE WEALTH PARTNERS LLC | 26 | 26 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 3 | — | — | 696 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 569 | 12.14K |
| Morgan Stanley | 2 | 2 | — | — | — | — | — | — | — | — | — | — | — | — | — | 562 | — | — | 3 | 500 |
| ARMISTICE CAPITAL, LLC | — | — | — | — | 81.65K | 322.18K | 411.00K | 27.20K | — | 28.00K | — | 218.00K | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 26.40K | — | — | — | — | 39.25K |
| Clear Street Group Inc. | — | — | — | 17.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GEODE CAPITAL MANAGEMENT, LLC | — | 20.20K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | — | 15.99K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold DRMA?
As of 2026-Q3, 15 institutional funds reported holding DRMA (DERMATA THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $186.81K.
How many shares of DRMA do institutions own?
13F filers reported 170.14K shares of DRMA, worth $186.81K in aggregate at the end of 2026-Q3.
Is institutional ownership of DRMA rising or falling?
Share counts moved -6.9% versus the prior quarter — distribution.
Who are the top institutional holders of DRMA?
The largest 13F holders are ARMISTICE CAPITAL, LLC, Clear Street Group Inc., Citadel Advisors, Renaissance Technologies, Two Sigma Investments; the top 25 are ranked at the top of this page.
Who are the major shareholders of DERMATA THERAPEUTICS INC?
The major shareholders of DERMATA THERAPEUTICS INC (DRMA) by reported 13F value are ARMISTICE CAPITAL, LLC, Clear Street Group Inc., Citadel Advisors, Renaissance Technologies, Two Sigma Investments, among 31 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.